Skip to search.
 TSX Up 0.21% TSX Ventures Up 1.43%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
1.72 Up 0.03(1.78%) Jul 29, 4:00PM EDT
|After Hours : 1.72 Down 0.00 (0.02%) Jul 29, 4:46PM EDT
Prev Close:1.69
Open:1.66
Bid:1.57 x 6000
Ask:8.00 x 200
1y Target Est:5.00
Beta:2.51047
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:1.66 - 1.72
52wk Range:1.19 - 4.42
Volume:308,495
Avg Vol (3m):604,465
Market Cap:208.66M
P/E (ttm):N/A
EPS (ttm):-0.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IDRAUp 1.78%208.66M
PFEUp 0.60%223.73B
DVAXDown 0.45%593.99M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):402.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.45
Quarterly EPS Est (Jun-16) :-0.11
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for oncology and rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback